"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

Thermo Fisher Scientific, Horizon Discovery, OriGene Technologies, QIAGEN, and GeneCopoeia Lead the Competition MicroRNA ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

The UK is poised to lead the next great leap in agriculture, with gene-editing technology offering a lifeline to a ...